Digital Literacy Projects Define TDCX Foundation’s First Year
SINGAPORE--(BUSINESS WIRE)--TDCX Foundation, the social impact arm of TDCX (NYSE: TDCX), an award-winning digital customer experience (CX) solutions provider for...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Wolters Kluwer accounting industry survey reveals revenue growth remains key focus in APAC region
Survey finds that accounting firms embracing innovation, technology and cloud solutions will thrive SYDNEY--(BUSINESS WIRE)--Wolters Kluwer, a global leader in...
HKTB Invites Visitors and Locals to “Hallo” Hong Kong Halloween
Explore the City for Hot-Spot Hunting and Night-Time Celebration HONG KONG--(BUSINESS WIRE)--Look out for adorable Halloween friends across Hong Kong!...
Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BEIJING, China--(BUSINESS WIRE)--Avistone Biotechnology Co., Ltd (“Avistone†or “the Companyâ€), a clinical-stage biotechnology company focused on precision oncology therapeutics, today...
Stronghold Announces Bitcoin Mining Update and Frontier Managed Services Agreement
NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Strongholdâ€, or the “Companyâ€) today provided...
Shaperon Inc. Makes a Splash at BioFutureâ„¢ 2023 With the Announcement of US Subsidiary Hudson Therapeutics Inc. and Positive Clinical Data
CAMBRIDGE, Mass. & SEOUL, South Korea--(BUSINESS WIRE)--Shaperon Inc. grabbed the spotlight at BioFutureâ„¢ 2023 as it confidently graced the stage,...
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) in Relapsed or Refractory Follicular Lymphoma
CHMP recommends approval for BRUKINSA plus obinutuzumab as a treatment for adult patients who have received at least two prior...
GU Releases Yu-Gi-Oh! Trading Card Game Special Collection
25th Anniversary sweatshirt box set NEW YORK--(BUSINESS WIRE)--GU, the Japanese apparel retailer with the brand theme “TOKYO TO SOHOâ€, announces...
GE Appliances Blue Wave Circles the Globe
Company celebrates yearlong volunteer commitment with projects in communities across the U.S. and three countries. LOUISVILLE, Ky.--(BUSINESS WIRE)--Today GE Appliances,...
HARMAN Launches New Private Large Language Model for Healthcare Industry- HARMAN HealthGPT
HARMAN HealthGPT enables healthcare enterprises to solve targeted problems by deep domain understanding, adaptability and continuous learning ability. BENGALURU, India--(BUSINESS...
Genome Insight, Inc. Announces Groundbreaking Research Collaboration with Shriners Children’s for Patients with Adolescent Idiopathic Scoliosis
Project aims to unravel the genetic etiology of Adolescent Idiopathic Scoliosis (AIS) by leveraging Genome Insight’s whole-genome sequencing analysis and...
GE Licensing, Current Lighting, Savant and Seoul Semiconductor Co., Ltd. Enter into Patent License Agreement
SEOUL, South Korea--(BUSINESS WIRE)--#KOSDAQ046890--GE Licensing (“GELâ€), Current Lighting Solutions, LLC (“Currentâ€), Savant Systems Inc. and Seoul Semiconductor Co., Ltd. (“SSCâ€)...
ABION Presents New Efficacy Data for ABN401, a Novel MET TKI for Advanced Non-Small Cell Lung Cancer
ABN401 demonstrates superior safety profile to existing treatments SEOUL, South Korea & BOSTON--(BUSINESS WIRE)--#aacr--ABION (KOSDAQ: 203400) today released data from...
Q4 DRAM Contract Prices Set to Rise, With Estimated Quarterly Increase of 3-8%, Says TrendForce
TAIPEI, Taiwan--(BUSINESS WIRE)--#DDR4--TrendForce reports indicate a universal price increase for both DRAM and NAND Flash starting in the fourth quarter....
Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183, Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Plaque Psoriasis at EADV Congress 2023
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that positive findings from...
